New research suggests that people who come off new weight-loss injections like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who end conventional diet and exercise regimens.
Findings released in a prominent medical journal demonstrates that while overweight people often shed a large proportion of their total mass while on the medication, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.
"Users buying such medications need to be aware of the danger of quick rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb.
Such speed of regain means a return to pre-treatment mass in about one and a half years.
Analyzing Approaches
The research, which reviewed dozens of studies involving over 9,000 of participants, compared the results of GLP-1 agonists with other pills.
Scientists note that people who shed pounds through lifestyle changes alone usually see a less rapid creep back—around 0.1 kg a month—once they finish.
The Reason for the Quick Regain
Doctors propose the way of the injections explains the accelerated rebound.
GLP-1 drugs mimic a natural hormone called GLP-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 concentrations far above than normal might result in the body to produce less of its own natural GLP-1, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Stopping of this medication results in appetite is unsuppressed, making excessive eating a significant risk."
A Chronic Condition?
Medical guidelines recommend the jabs for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Many experts say that, considering the significant potential of weight regain, the therapy is often life-long.
This perspective is reinforced by drug manufacturers, who note that the findings "underscore the long-term nature of excess weight," akin to managing diseases like diabetes.
User Testimonies
People who have come off the jabs describe a intense return of appetite.
"It felt as if a trigger that goes on and you become ravenous," said an individual.
This difficulty is exacerbated if users have not developed lasting lifestyle or habit modifications during treatment.
Significant Interest
Survey data suggest that millions of adults in the UK have used these injections in the past year, with desire being substantial.
- Use is more common among women than men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
Ultimately, clinicians emphasize that while GLP-1 drugs are powerful agents for weight loss, they are not a magic fix and lasting health benefits hinges on ongoing lifestyle support.
